BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 27362735)

  • 1. Asymptomatic C-reactive protein elevation in neutropenic children.
    Sugiura S; Ito T; Koyama N; Sasaki N; Ikai H; Imanaka Y
    Pediatr Int; 2017 Jan; 59(1):23-28. PubMed ID: 27362735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies.
    El-Maghraby SM; Moneer MM; Ismail MM; Shalaby LM; El-Mahallawy HA
    J Pediatr Hematol Oncol; 2007 Mar; 29(3):131-6. PubMed ID: 17356388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of serum endothelial adhesion molecules in pediatric patients with leukemia with febrile neutropenia to predict bacteremia.
    Arıkan K; Karadağ-Oncel E; Aytac S; Cengiz AB; Duygu Cetinkaya F; Kara A; Ceyhan M
    Cytokine; 2021 Dec; 148():155692. PubMed ID: 34500368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of C-reactive protein during febrile neutropenia in pediatric malignancies.
    Avabratha KS; Rau AT; Venkataravanamma P; Rau A
    Indian Pediatr; 2009 Sep; 46(9):797-9. PubMed ID: 19430077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric Febrile Neutropenia: Change in Etiology of Bacteremia, Empiric Choice of Therapy and Clinical Outcomes.
    Alali M; David MZ; Danziger-Isakov LA; Elmuti L; Bhagat PH; Bartlett AH
    J Pediatr Hematol Oncol; 2020 Aug; 42(6):e445-e451. PubMed ID: 32404688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis.
    Lucas KG; Brown AE; Armstrong D; Chapman D; Heller G
    Cancer; 1996 Feb; 77(4):791-8. PubMed ID: 8616774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic prophylaxis with teicoplanin on alternate days reduces rate of viridans sepsis and febrile neutropenia in pediatric patients with acute myeloid leukemia.
    Boztug H; Mühlegger N; Pötschger U; Attarbaschi A; Peters C; Mann G; Dworzak M
    Ann Hematol; 2017 Jan; 96(1):99-106. PubMed ID: 27699447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urine cultures at the onset of febrile neutropenia rarely impact antibiotic management in asymptomatic adult cancer patients.
    Grigg SE; Date P; Loh Z; Estacio O; Johnson DF; Hawkes EA; Grigg A
    Support Care Cancer; 2019 Apr; 27(4):1223-1227. PubMed ID: 30259115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
    Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
    Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of repeat blood cultures during febrile neutropenia in adult acute myeloid leukaemia patients undergoing intensive chemotherapy.
    Kimura SI; Gomyo A; Hayakawa J; Tamaki M; Akahoshi Y; Harada N; Ugai T; Kusuda M; Kameda K; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Terasako-Saito K; Kikuchi M; Nakasone H; Kako S; Tanihara A; Kanda Y
    Infect Dis (Lond); 2017 Oct; 49(10):748-757. PubMed ID: 28631944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential efficacy of empirical antibiotic therapy for febrile neutropenia in adolescent/young adult (AYA) and child patients.
    Sano H; Kobayashi R; Suzuki D; Kishimoto K; Hori D; Matsushima S; Yoshida M; Sarashina T; Toriumi N; Kobayashi K
    Int J Hematol; 2018 Nov; 108(5):543-549. PubMed ID: 30039441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Characterization of episodes of febrile neutropenia in children with acute myeloid leukemia and acute lymphoblastic leukemia].
    Ducasse K; Fernández JP; Salgado C; Alvarez AM; Avilés CL; Becker A; Topelberg S; Tordecilla J; Varas M; Villarroel M; Viviani T; Zubieta M; Santolaya ME
    Rev Chilena Infectol; 2014 Jun; 31(3):333-8. PubMed ID: 25146209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy of cycling empirical antibiotic therapy for febrile neutropenia in pediatric cancer patients.
    Teranishi H; Koga Y; Nishio H; Kato W; Ono H; Kanno S; Nakashima K; Takada H
    J Infect Chemother; 2017 Jul; 23(7):463-467. PubMed ID: 28527651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of empiric antibiotic de-escalation in febrile neutropenia.
    Kroll AL; Corrigan PA; Patel S; Hawks KG
    J Oncol Pharm Pract; 2016 Oct; 22(5):696-701. PubMed ID: 26227319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized trial of cefozopran versus cefepime as empirical antibiotic treatment of febrile neutropenia in pediatric cancer patients.
    Sarashina T; Kobayashi R; Yoshida M; Toriumi N; Suzuki D; Sano H; Azuma H
    Pediatr Blood Cancer; 2014 Nov; 61(11):1992-5. PubMed ID: 25130289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk index score for bacteremia in febrile neutropenic episodes in children with malignancies.
    Spasova MI; Grudeva-Popova JG; Kostyanev SS; Genev ED; Stoyanova AA; Kirina VI; Moumdjiev IN
    J BUON; 2009; 14(3):411-8. PubMed ID: 19810131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etiology and Factors Affecting Severe Complications and Mortality of Febrile Neutropenia in Children with Acute Leukemia.
    Erbaş İC; Çakıl Güzin A; Özdem Alataş Ş; Karaoğlu Asrak H; Akans İ; Akyol Ş; Özlü C; Tüfekçi Ö; Yılmaz Ş; Ören H; Belet N
    Turk J Haematol; 2023 Aug; 40(3):143-153. PubMed ID: 37525503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors predicting outcome in high risk febrile neutropenia in patients receiving intensive chemotherapy for acute sleukemia: A prospective, observational study from South India.
    Rajendranath R; Balasubramaniyum VK; Vijayakumar V; Ganesan P; Tenali GS
    Indian J Cancer; 2014; 51(4):481-6. PubMed ID: 26842171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Febrile Neutropenia Syndromes in Children: Risk Factors and Outcomes of Primary, Prolonged, and Recurrent Fever.
    Alali M; David MZ; Ham SA; Danziger-Isakov L; Pisano J
    J Pediatr Hematol Oncol; 2021 Oct; 43(7):e962-e971. PubMed ID: 34133386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric fever in neutropenia with bacteremia-Pathogen distribution and in vitro antibiotic susceptibility patterns over time in a retrospective single-center cohort study.
    Stergiotis M; Ammann RA; Droz S; Koenig C; Agyeman PKA
    PLoS One; 2021; 16(2):e0246654. PubMed ID: 33577566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.